Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 52Brain Neoplasms 50Carcinoma, Non-Small-Cell Lung 48Neoplasm Metastasis 29Lung Neoplasms 29Breast Neoplasms 23Pancreatic Neoplasms 16Melanoma 15Carcinoma, Renal Cell 14Carcinoma, Hepatocellular 13Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Urinary Bladder Neoplasms 7Small Cell Lung Carcinoma 7Colorectal Neoplasms 7Kidney Neoplasms 5Liver Neoplasms 4Glioblastoma 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Prostate Cancer Metastatic 3NSCLC 3Meningioma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Transitional Cell 3Adenocarcinoma 3

Interventions

Radiosurgery 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PSA Level Greater Than 0.03 × Radiosurgery × 1 year × Clear all
NCT03541850 2025-11-06

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Jonsson Comprehensive Cancer Center

Phase 2 Active not recruiting
92 enrolled
Genitourinary

PSA Level Greater Than 0.03

Data powered by HemOnc (CC BY 4.0) Colophon âš¡